PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy

Journal of Cell Biology

Volumn 196, Issue 1, 2012, Pages 163-175

  Ardite, Esther ^a,b   Perdiguero, Eusebio ^a,b   Vidal, Berta ^a,b   Gutarra, Susana ^a,b   Serrano, Antonio L ^a,b   Muñoz Cánoves, Pura ^a,b,c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MICRORNA 21; PHOSPHATASE; TENSIN; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

ADOLESCENT; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CHILD; COLLAGEN METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FIBROBLAST; FIBROGENESIS; GENE LOSS; HUMAN; HUMAN TISSUE; MALE; MOUSE; MUSCULAR DYSTROPHY; MYOFIBROSIS; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SCHOOL CHILD; WESTERN BLOTTING;

ADOLESCENT; AGE FACTORS; ANIMALS; CELL PROLIFERATION; CHILD; COLLAGEN; FEMALE; FIBROSIS; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; MUSCULAR DYSTROPHIES; PROTO-ONCOGENE PROTEINS C-AKT; SERPIN E2; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 84856695092     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201105013     Document Type: Article

References (42)

1. Andreetta, F., P. Bernasconi, F. Baggi, P. Ferro, L. Oliva, E. Arnoldi, F. Cornelio, R. Mantegazza, and P. Confalonieri. 2006. Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy. J. Neuroimmunol. 175:77-86. http://dx.doi.org/10.1016/j.jneuroim.2006.03.005
2. Carmeliet, P., and D. Collen. 1994. Evaluation of the plasminogen/plasmin system in transgenic mice. Fibrinolysis. 8:269-276. http://dx.doi.org/10.1016/0268-9499(94)90725-0
3. Carmeliet, P., L. Kieckens, L. Schoonjans, B. Ream, A. van Nuffelen, G. Prendergast, M. Cole, R. Bronson, D. Collen, and R.C. Mulligan. 1993. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J. Clin. Invest. 92: 2746-2755. http://dx.doi.org/10.1172/JCI116892
4. Davis, B.N., A.C. Hilyard, G. Lagna, and A. Hata. 2008. SMAD proteins control DROSHA-mediated microRNA maturation. Nature. 454:56-61. http://dx.doi.org/10.1038/nature07086
5. Deconinck, N., and B. Dan. 2007. Pathophysiology of duchenne muscular dystrophy: Current hypotheses. Pediatr. Neurol. 36:1-7. http://dx.doi.org/10.1016/j.pediatrneurol.2006.09.016
6. Flier, S.N., H. Tanjore, E.G. Kokkotou, H. Sugimoto, M. Zeisberg, and R. Kalluri. 2010. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J. Biol. Chem. 285:20202-20212. http://dx.doi.org/10.1074/jbc.M110.102012
7. Gargioli, C., M. Coletta, F. De Grandis, S.M. Cannata, and G. Cossu. 2008. PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle. Nat. Med. 14:973-978. http://dx.doi.org/10.1038/nm.1852
8. George, S.J., J.L. Johnson, M.A. Smith, G.D. Angelini, and C.L. Jackson. 2005. Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein. J. Vasc. Res. 42:247-254. http://dx.doi.org/10.1159/000085657
9. Hayashida, T. 2010. Integrins modulate cellular fibrogenesis at multiple levels; Regulation of TGF-β signaling. Endocr. Metab. Immune Disord. Drug Targets. 10:302-319.
10. Howell, J.E., and R.J. McAnulty. 2006. TGF-beta: Its role in asthma and therapeutic potential. Curr. Drug Targets. 7:547-565. http://dx.doi.org/10.2174/138945006776818692
11. Hutvágner, G., M.J. Simard, C.C. Mello, and P.D. Zamore. 2004. Sequencespecific inhibition of small RNA function. PLoS Biol. 2:E98. http://dx.doi.org/10.1371/journal.pbio.0020098
12. Krichevsky, A.M., and G. Gabriely. 2009. miR-21: A small multi-faceted RNA. J. Cell. Mol. Med. 13:39-53. http://dx.doi.org/10.1111/j.1582-4934.2008.00556.x
13. Krützfeldt, J., N. Rajewsky, R. Braich, K.G. Rajeev, T. Tuschl, M. Manoharan, and M. Stoffel. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 438:685-689. http://dx.doi.org/10.1038/nature04303
14. Liu, G., A. Friggeri, Y. Yang, J. Milosevic, Q. Ding, V.J. Thannickal, N. Kaminski, and E. Abraham. 2010. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 207:1589-1597. http://dx.doi.org/10.1084/jem.20100035
15. Liu, X., H. Hu, and J.Q. Yin. 2006. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int. 26:8-22. http://dx.doi.org/10.1111/j.1478-3231.2005.01192.x
16. Lluís, F., J. Roma, M. Suelves, M. Parra, G. Aniorte, E. Gallardo, I. Illa, L. Rodríguez, S.M. Hughes, P. Carmeliet, et al. 2001. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood. 97:1703-1711. http://dx.doi.org/10.1182/blood.V97.6.1703
17. Ludbrook, S.B., S.T. Barry, C.J. Delves, and C.M. Horgan. 2003. The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3. Biochem. J. 369:311-318. http://dx.doi.org/10.1042/BJ20020809
18. Mann, C.J., E. Perdiguero, Y. Kharraz, S. Aguilar, P. Pessina, A.L. Serrano, and P. Muñoz-Cánoves. 2011. Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle. 1:21. http://dx.doi.org/10.1186/2044-5040-1-21
19. Mathew, S.J., J.M. Hansen, A.J. Merrell, M.M. Murphy, J.A. Lawson, D.A. Hutcheson, M.S. Hansen, M. Angus-Hill, and G. Kardon. 2011. Connective tissue fibroblasts and Tcf4 regulate myogenesis. Development. 138: 371-384. http://dx.doi.org/10.1242/dev.057463
20. Medina, P.P., M. Nolde, and F.J. Slack. 2010. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature. 467:86-90. http://dx.doi.org/10.1038/nature09284
21. Menetrey, J., C. Kasemkijwattana, F.H. Fu, M.S. Moreland, and J. Huard. 1999. Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am. J. Sports Med. 27:222-229.
22. Murphy, M.M., J.A. Lawson, S.J. Mathew, D.A. Hutcheson, and G. Kardon. 2011. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development. 138:3625-3637. http://dx.doi.org/10.1242/dev.064162
23. Nunes, I., R.L. Shapiro, and D.B. Rifkin. 1995. Characterization of latent TGFbeta activation by murine peritoneal macrophages. J. Immunol. 155: 1450-1459.
24. Odekon, L.E., F. Blasi, and D.B. Rifkin. 1994. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J. Cell. Physiol. 158:398-407. http://dx.doi.org/10.1002/jcp.1041580303
25. Okada, H., T.M. Danoff, R. Kalluri, and E.G. Neilson. 1997. Early role of Fsp1 in epithelial-mesenchymal transformation. Am. J. Physiol. 273:F563-F574.
26. Pan, X., Z.X. Wang, and R. Wang. 2011. MicroRNA-21: A novel therapeutic target in human cancer. Cancer Biol. Ther. 10:1224-1232.
27. Patrick, D.M., R.L. Montgomery, X. Qi, S. Obad, S. Kauppinen, J.A. Hill, E. van Rooij, and E.N. Olson. 2010. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 120:3912-3916. http://dx.doi.org/10.1172/JCI43604
28. Pedroja, B.S., L.E. Kang, A.O. Imas, P. Carmeliet, and A.M. Bernstein. 2009. Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling. J. Biol. Chem. 284:20708-20717. http://dx.doi.org/10.1074/jbc.M109.018804
29. Perdiguero, E., V. Ruiz-Bonilla, L. Gresh, L. Hui, E. Ballestar, P. Sousa-Victor, B. Baeza-Raja, M. Jardí, A. Bosch-Comas, M. Esteller, et al. 2007. Genetic analysis of p38 MAP kinases in myogenesis: Fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J. 26:1245-1256. http://dx.doi.org/10.1038/sj.emboj.7601587
30. Serrano, A.L., and P. Muñoz-Cánoves. 2010. Regulation and dysregulation of fibrosis in skeletal muscle. Exp. Cell Res. 316:3050-3058. http://dx.doi.org/10.1016/j.yexcr.2010.05.035
31. Silahtaroglu, A.N., D. Nolting, L. Dyrskjøt, E. Berezikov, M. Møller, N. Tommerup, and S. Kauppinen. 2007. Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat. Protoc. 2:2520-2528. http://dx.doi.org/10.1038/nprot.2007.313
32. Stedman, H.H., H.L. Sweeney, J.B. Shrager, H.C. Maguire, R.A. Panettieri, B. Petrof, M. Narusawa, J.M. Leferovich, J.T. Sladky, and A.M. Kelly. 1991. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 352:536-539. http://dx.doi.org/10.1038/352536a0
33. Suelves, M., R. López-Alemany, F. Lluís, G. Aniorte, E. Serrano, M. Parra, P. Carmeliet, and P. Muñoz-Cánoves. 2002. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood. 99:2835-2844. http://dx.doi.org/10.1182/blood.V99.8.2835
34. Suelves, M., B. Vidal, V. Ruiz, B. Baeza-Raja, A. Diaz-Ramos, I. Cuartas, F. Lluis, M. Parra, M. Jardi, R. Lopez-Alemany, et al. 2005. The plasminogen activation system in skeletal muscle regeneration: Antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1). Front. Biosci. 10:2978-2985. http://dx.doi.org/10.2741/1754
35. Suelves, M., B. Vidal, A.L. Serrano, M. Tjwa, J. Roma, R. López-Alemany, A. Luttun, M.M. de Lagrán, A. Díaz-Ramos, M. Jardí, et al. 2007. uPA deficiency exacerbates muscular dystrophy in MDX mice. J. Cell Biol. 178:1039-1051. http://dx.doi.org/10.1083/jcb.200705127
36. Thum, T., C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, P. Galuppo, S. Just, W. Rottbauer, S. Frantz, et al. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 456:980-984. http://dx.doi.org/10.1038/nature07511
37. Varga, J., and B. Pasche. 2009. Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol. 5:200-206. http://dx.doi.org/10.1038/nrrheum.2009.26
38. Vidal, B., A.L. Serrano, M. Tjwa, M. Suelves, E. Ardite, R. De Mori, B. Baeza-Raja, M. Martínez de Lagrán, P. Lafuste, V. Ruiz-Bonilla, et al. 2008. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev. 22:1747-1752. http://dx.doi.org/10.1101/gad.465908
39. Worthington, J.J., J.E. Klementowicz, and M.A. Travis. 2011. TGFβ: A sleeping giant awoken by integrins. Trends Biochem. Sci. 36:47-54. http://dx.doi.org/10.1016/j.tibs.2010.08.002
40. Yee, J.A., L. Yan, J.C. Dominguez, E.H. Allan, and T.J. Martin. 1993. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells. J. Cell. Physiol. 157:528-534. http://dx.doi.org/10.1002/jcp.1041570312
41. Zeng, Y., and B.R. Cullen. 2003. Sequence requirements for micro RNA processing and function in human cells. RNA. 9:112-123. http://dx.doi.org/10.1261/rna.2780503
42. Zhou, L., and H. Lu. 2010. Targeting fibrosis in Duchenne muscular dystrophy. J. Neuropathol. Exp. Neurol. 69:771-776. http://dx.doi.org/10.1097/NEN.0b013e3181e9a34b